These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 30968645)

  • 1. Sustained hyperferritinemia in a child with macrophage activation syndrome secondary to systemic juvenile idiopathic arthritis - perforinopathy: case based review.
    Çakan M; Aktay-Ayaz N; Gemici H; Annayev A; Çıtak A; Akçay A; Öztürk G
    Turk J Pediatr; 2018; 60(5):598-603. PubMed ID: 30968645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic.
    Soy M; Atagündüz P; Atagündüz I; Sucak GT
    Rheumatol Int; 2021 Jan; 41(1):7-18. PubMed ID: 32588191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic plasma exchange in refractory macrophage activation syndrome complicating systemic juvenile idiopathic arthritis: a case-based review.
    Liquidano-Perez E; Maza-Ramos G; Salazar-Bailón JL; Yamazaki-Nakashimada MA; Rivas-Larrauri F
    Rheumatol Int; 2023 Jan; 43(1):183-189. PubMed ID: 36264324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophagocytic lymphocytic histiocytosis/macrophage activation syndrome with acute inflammatory gastroenteritis.
    Kolachana S; Malik A; Nanjudappa A; Iding J; Bhansali D; Haas CJ
    BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36002177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of current guidelines for diagnosis of macrophage activation syndrome complicating systemic juvenile idiopathic arthritis.
    Davì S; Minoia F; Pistorio A; Horne A; Consolaro A; Rosina S; Bovis F; Cimaz R; Gamir ML; Ilowite NT; Kone-Paut I; Feitosa de Oliveira SK; McCurdy D; Silva CA; Sztajnbok F; Tsitsami E; Unsal E; Weiss JE; Wulffraat N; Abinun M; Aggarwal A; Apaz MT; Astigarraga I; Corona F; Cuttica R; D'Angelo G; Eisenstein EM; Hashad S; Lepore L; Mulaosmanovic V; Nielsen S; Prahalad S; Rigante D; Stanevicha V; Sterba G; Susic G; Takei S; Trauzeddel R; Zletni M; Ruperto N; Martini A; Cron RQ; Ravelli A;
    Arthritis Rheumatol; 2014 Oct; 66(10):2871-80. PubMed ID: 25044674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The History of Macrophage Activation Syndrome in Autoimmune Diseases.
    Silverman ED
    Adv Exp Med Biol; 2024; 1448():21-31. PubMed ID: 39117805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An unusual presentation of purine nucleoside phosphorylase deficiency mimicking systemic juvenile idiopathic arthritis complicated by macrophage activation syndrome.
    Arduini A; Marasco E; Marucci G; Pardeo M; Insalaco A; Caiello I; Moneta GM; Prencipe G; De Benedetti F; Bracaglia C
    Pediatr Rheumatol Online J; 2019 May; 17(1):25. PubMed ID: 31118063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?
    Demirkol D; Yildizdas D; Bayrakci B; Karapinar B; Kendirli T; Koroglu TF; Dursun O; Erkek N; Gedik H; Citak A; Kesici S; Karabocuoglu M; Carcillo JA;
    Crit Care; 2012 Dec; 16(2):R52. PubMed ID: 22715953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical features and correct diagnosis of macrophage activation syndrome.
    Cron RQ; Davi S; Minoia F; Ravelli A
    Expert Rev Clin Immunol; 2015; 11(9):1043-53. PubMed ID: 26082353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristic elevation of soluble TNF receptor II : I ratio in macrophage activation syndrome with systemic juvenile idiopathic arthritis.
    Shimizu M; Inoue N; Mizuta M; Nakagishi Y; Yachie A
    Clin Exp Immunol; 2018 Mar; 191(3):349-355. PubMed ID: 28815559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokines in systemic juvenile idiopathic arthritis and haemophagocytic lymphohistiocytosis: tipping the balance between interleukin-18 and interferon-γ.
    Put K; Avau A; Brisse E; Mitera T; Put S; Proost P; Bader-Meunier B; Westhovens R; Van den Eynde BJ; Orabona C; Fallarino F; De Somer L; Tousseyn T; Quartier P; Wouters C; Matthys P
    Rheumatology (Oxford); 2015 Aug; 54(8):1507-17. PubMed ID: 25767156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Macrophage activation syndrome in a patient with systemic juvenile idiopathic arthritis].
    Tavares AC; Ferreira GA; Guimarães LJ; Guimarães RR; Santos FP
    Rev Bras Reumatol; 2015; 55(1):79-82. PubMed ID: 25575650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole-exome sequencing reveals overlap between macrophage activation syndrome in systemic juvenile idiopathic arthritis and familial hemophagocytic lymphohistiocytosis.
    Kaufman KM; Linghu B; Szustakowski JD; Husami A; Yang F; Zhang K; Filipovich AH; Fall N; Harley JB; Nirmala NR; Grom AA
    Arthritis Rheumatol; 2014 Dec; 66(12):3486-95. PubMed ID: 25047945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fever of unknown origin in a patient of systemic onset juvenile idiopathic arthritis.
    Vishwanath VK; Krishnamurthy A; Karyampudi A; Dutta TK
    Indian J Med Sci; 2010 Jul; 64(7):333-6. PubMed ID: 22918076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complications of complications: diagnosis and treatment of recurrent macrophage activation syndrome in a patient with well-controlled systemic juvenile idiopathic arthritis.
    Macaraeg M; Schulert GS
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36690384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of Moderately Dosed Etoposide in Macrophage Activation Syndrome-Hemophagocytic Lymphohistiocytosis.
    Horne A; von Bahr Greenwood T; Chiang SCC; Meeths M; Björklund C; Ekelund M; Erensjö P; Berg S; Hagelberg S; Bryceson YT; Andersson U; Henter JI
    J Rheumatol; 2021 Oct; 48(10):1596-1602. PubMed ID: 33589555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic Juvenile Idiopathic Arthritis.
    Lee JJY; Schneider R
    Pediatr Clin North Am; 2018 Aug; 65(4):691-709. PubMed ID: 30031494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Killer Cells in Systemic Autoinflammatory Diseases: A Focus on Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome.
    Vandenhaute J; Wouters CH; Matthys P
    Front Immunol; 2019; 10():3089. PubMed ID: 32010140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage activation syndrome in children with systemic juvenile idiopathic arthritis and systemic lupus erythematosus.
    Aytaç S; Batu ED; Ünal Ş; Bilginer Y; Çetin M; Tuncer M; Gümrük F; Özen S
    Rheumatol Int; 2016 Oct; 36(10):1421-9. PubMed ID: 27510530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin.
    Sztajnbok F; Fonseca AR; Campos LR; Lino K; Rodrigues MCF; Silva RM; de Almeida RG; Perazzio SF; Carvalho MFF
    Adv Rheumatol; 2024 Apr; 64(1):28. PubMed ID: 38627860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.